Updated Jul 16, 2026 · Last SEC filing 2024-11-18
Cyclo Therapeutics, Inc. (CYTH) — no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every CYTH SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0000922247 |
|---|
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| SHANAHAN WILLIAM S | Director | A — Grant or award | 15.1K | $0.00 | — | SEC | |
| Sieger Markus | Director | A — Grant or award | 35.0K | $0.00 | — | SEC | |
| Wong Vivien | Director | A — Grant or award | 15.1K | $0.00 | — | SEC | |
| Cross Shawn | Director | A — Grant or award | 17.2K | $0.00 | — | SEC | |
| Toig Randall M. | Director | A — Grant or award | 20.1K | $0.00 | — | SEC | |
| CONKLING WILLIAM | Director | A — Grant or award | 16.7K | $0.00 | — | SEC | |
| STRATTAN CE RICK | Director | A — Grant or award | 63.6K | $0.00 | — | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Cyclo Therapeutics, Inc. (CYTH). Updated in real time as new filings are submitted to the SEC.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in CYTH insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live CYTH dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.